A Retrospective Study: Evaluating the Impact of the COVID-19 Pandemic on Inflammatory Markers in Hospitalized Patients
Authors:
- Elmoeiz A. ElnagiEEElmoeiz A. Elnagi
- Thekra N. Al-MaqatiTAThekra N. Al-Maqati
- Rawan M. MaawadhRMRawan M. Maawadh
- Salma AlBahraniSASalma AlBahrani
- Faisal Salem Al KhalafFKFaisal Salem Al Khalaf
- Faisal M. AlzahraniFAFaisal M. Alzahrani
- Wael NazzalWNWael Nazzal
- Maha AlanaziMAMaha Alanazi
- Abdullah S. AbdaliAAAbdullah S. Abdali
- Amjad Saleh Al AtawiAAAmjad Saleh Al Atawi
- Lamiaa H. Al-JameaLALamiaa H. Al-Jamea
- Ahmad Mohammad AlshehriAAAhmad Mohammad Alshehri
Open Access
- 14 August 2024
- journal article
- research article
- Published by MDPI AG in Infectious Disease Reports
- Vol. 16 (4) , 735-749
Abstract
Background: The COVID-19 pandemic has had a significant impact globally, and understanding the relationship between inflammatory markers and disease progression is crucial for effective management. This retrospective study aimed to examine the association between various inflammatory markers, such as C-reactive protein (CRP), the erythrocyte sedimentation rate (ESR), lactate dehydrogenase (LDH), D-dimer, ferritin, and procalcitonin (PCT), and the characteristics of disease progression and outcomes in individuals affected by COVID-19. Methods: This study collected raw data from 470 patients who tested positive for SARS-CoV-2 using RT-PCR. Results: The logistic regression analysis revealed that elevated LDH levels were associated with male gender, ICU admission, low oxygen saturation (O2 < 93%), the need for mechanical ventilation, death, and the presence of lung infiltrates. Higher D-dimer levels were associated with older age, diabetes mellitus, cardiac disease, and low oxygen saturation. Ferritin levels were significantly associated with older age, ICU admission, low oxygen saturation, mechanical ventilation, and lung infiltrates. In contrast, CRP was only significant regarding lung infiltrates and procalcitonin levels were not significantly associated with any of the examined factors. Conclusion: This study highlights the importance of monitoring key inflammatory markers, such as LDH, D-dimer, and ferritin, as they are significantly associated with the severity of COVID-19 illness. These findings can inform clinical decision-making and guide the development of targeted interventions to improve patient outcomes.Keywords
This publication has 65 references indexed in Scilit:
- Emerging treatment strategies for COVID-19 infectionClinical and Experimental Medicine, 2020
- Risk factors for Covid-19 severity and fatality: a structured literature reviewInfection, 2020
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemicRheumatology International, 2020
- Elevated level of C‐reactive protein may be an early marker to predict risk for severity of COVID‐19Journal of Medical Virology, 2020
- COVID-19: Immunology and treatment optionsClinical Immunology, 2020
- Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysisClinica Chimica Acta, 2020
- Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysisThe American Journal of Emergency Medicine, 2020
- C-reactive protein: Ligands, receptors and role in inflammationClinical Immunology, 2005
- High serum procalcitonin concentrations in patients with sepsis and infectionThe Lancet, 1993